Jazz Pharmaceuticals JAZZ along with partner Zymeworks ZYME announced positive tolerability and efficacy results from an ongoing phase II study on zanidatamab, an investigational HER2-targeted ...
The 2024-25 NBA season is still very much in its infancy stages. Statistics and trends require a larger sample size to stabilize, while most teams have only played six or seven games of 82. But for ...
June 20 (Reuters) - Jazz Pharmaceuticals (JAZZ.O), opens new tab said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, ...
Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination regimens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results